Prevalence and patient awareness of medical comorbidities in an urban AIDS clinic
- PMID: 20095901
- PMCID: PMC2859780
- DOI: 10.1089/apc.2009.0152
Prevalence and patient awareness of medical comorbidities in an urban AIDS clinic
Abstract
Mortality in HIV-positive persons is increasingly due to non-HIV-related medical comorbidities. There are limited data on the prevalence and patient awareness of these comorbid conditions. Two hundred subjects at an urban HIV clinic were interviewed in 2005 to assess their awareness of 15 non-HIV-related medical comorbidities, defined as medical problems that are neither AIDS-defining by standard definitions, nor a direct effect of immune deficiency. Medical charts were subsequently reviewed to establish prevalence and concordance between self-report and chart documentation. Eighty-four percent of subjects self-reported at least 1 of 15 medical comorbidities and 92% had at least 1 condition chart-documented. The top 5 chart-documented conditions were hepatitis C (51.5%), pulmonary disease (28.5%), high blood pressure (27%), high cholesterol (24.5%), and obesity (22.5%). In multivariate analysis, higher number of non-HIV-related medical comorbidities was associated with older age, female gender, and intravenous drug use as route of HIV transmission. Across self-reported non-HIV-related medical comorbidities, the absolute concordance rate ranged from 67% to 96%, the sensitivity ranged from 0% to 79%; the positive predictive value ranged from 0% to 100%. While the vast majority of largely urban minority HIV-positive subjects were diagnosed with non-HIV-related medical comorbidities, there is significant room for improvement in patient awareness. In order to help patients optimally access and adhere to medication and medical care for these non-HIV-related medical comorbidities, interventions and educational campaigns to improve patient awareness that take cultural background, literacy, and educational level into account should be developed, implemented, and evaluated.
Figures
Similar articles
-
Surveillance of AIDS-defining conditions in the United States. Adult/Adolescent Spectrum of HIV Disease Project Group.AIDS. 1994 Oct;8(10):1489-93. doi: 10.1097/00002030-199410000-00018. AIDS. 1994. PMID: 7818822
-
The clinical profile of end-stage AIDS in the era of highly active antiretroviral therapy.AIDS Patient Care STDS. 2002 Feb;16(2):75-81. doi: 10.1089/10872910252806126. AIDS Patient Care STDS. 2002. PMID: 11874639
-
Clinical features of tuberculosis associated with HIV infection in Taiwan.J Formos Med Assoc. 1996 Dec;95(12):923-8. J Formos Med Assoc. 1996. PMID: 9000809
-
The human immunodeficiency virus epidemic in India. Current magnitude and future projections.Medicine (Baltimore). 1995 Mar;74(2):97-106. doi: 10.1097/00005792-199503000-00005. Medicine (Baltimore). 1995. PMID: 7891548 Review.
-
Comorbidities of HIV-1/AIDS in adults.J Assoc Nurses AIDS Care. 1994 Nov-Dec;5(6):35-44. J Assoc Nurses AIDS Care. 1994. PMID: 7865805 Review.
Cited by
-
Correctional facilities as partners in reducing HIV disparities.J Acquir Immune Defic Syndr. 2013 Jun 1;63 Suppl 1(0 1):S49-53. doi: 10.1097/QAI.0b013e318292fe4c. J Acquir Immune Defic Syndr. 2013. PMID: 23673887 Free PMC article. Review.
-
A Cohort Pilot Study on HIV-Associated Neuropsychological Impairments in Hemophilia Patients.Front Hum Neurosci. 2015 Jun 2;9:313. doi: 10.3389/fnhum.2015.00313. eCollection 2015. Front Hum Neurosci. 2015. PMID: 26082706 Free PMC article.
-
Measuring disability experienced by adults living with HIV: assessing construct validity of the HIV Disability Questionnaire using confirmatory factor analysis.BMJ Open. 2014 Sep 1;4(8):e005456. doi: 10.1136/bmjopen-2014-005456. BMJ Open. 2014. PMID: 25180054 Free PMC article.
-
The aggregate effects of multiple comorbid risk factors on cognition among HIV-infected individuals.J Clin Exp Neuropsychol. 2013;35(4):421-34. doi: 10.1080/13803395.2013.783000. Epub 2013 Apr 3. J Clin Exp Neuropsychol. 2013. PMID: 23547924 Free PMC article.
-
HIV, HCV, and Health-Related Harms Among Women Who Inject Drugs: Implications for Prevention and Treatment.J Acquir Immune Defic Syndr. 2015 Jun 1;69 Suppl 2(0 1):S176-81. doi: 10.1097/QAI.0000000000000659. J Acquir Immune Defic Syndr. 2015. PMID: 25978485 Free PMC article. Review.
References
-
- Sackoff JE. Hanna DB. Pfeiffer MR. Torian LV. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med. 2006;145:397–406. - PubMed
-
- Crum NF. Riffenburgh RH. Wegner S, et al. Comparisons of causes of death and mortality rates among HIV-infected persons: Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr. 2006;41:194–200. - PubMed
-
- Bica I. McGovern B. Dhar R, et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis. 2001;32:492–497. - PubMed
-
- Lacombe K. Pacanowski J. [HIV infection and comorbidities] Rev Prat. 2006;56:995–1004. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical